Search

everythinglearnresearchcommunity

for

Search:↓

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.

Transgender youth have more sleep disorders, but gender-affirming therapy may help reduce them.

Probiotics and synbiotics might help manage hirsutism by improving insulin resistance.

A woman's virilization symptoms were caused by her partner's use of testosterone cream, which resolved after they separated.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Spironolactone may help women with hidradenitis suppurativa.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

A new method effectively detects trace sex hormones in cosmetics, ensuring safety.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Auriculotherapy and Aslagh capsules are as effective as metformin for treating PCOS symptoms, with auriculotherapy slightly better for reducing hair growth.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Balanced hormones are crucial for women's health, and can be managed with lifestyle changes or hormone therapy if needed.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

The conclusion is that different treatments improved hair growth in dogs with Alopecia X, but results varied and not all dogs had complete hair regrowth.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

IGF-1R may play a role in female hair loss and could be a treatment target.

Vitamin D and its receptor may help prevent skin cancer.

PCOS in teen girls should be managed with lifestyle changes and sometimes medication to improve symptoms and health.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

The new system greatly improves carvedilol's solubility and effectiveness.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Menopausal hormone therapy is best for hot flashes, while other options include SSRIs, SNRIs, fezolinetant, and lifestyle changes.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Allopregnanolone affects fear responses differently in male and female rats, possibly explaining sex differences in anxiety disorders.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.